Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ned Tijdschr Geneeskd ; 161: D1356, 2017.
Article in Dutch | MEDLINE | ID: mdl-28659207

ABSTRACT

BACKGROUND: The use of 4-fluoroamphetamine (4-FA) has shown a marked increase, especially because users perceive its effects to be relatively mild. 4-FA is also known as ecstacy-light, but is probably not as light as its name suggests. From April 2017 its use has therefore been forbidden in the Netherlands. CASE DESCRIPTION: In a short time, we saw three patients at our emergency department who had signs of a severe intoxication with 4-FA. A 21-year-old male developed a tonic-clonic seizure, bruxism, mydriasis, and rhabdomyolysis. A 19-year-old female was confused and was longing for death. A 22-year-old male needed to be admitted to intensive care to be intubated, sedated and cooled due to tachycardia, hypertension and hyperthermia. CONCLUSION: Because of its relatively mild effects, 4-FA is gaining in popularity in the Netherlands. However, the use of this designer drug can lead to severe problems such as severe confusion, hyperthermia and tonic-clonic seizures.


Subject(s)
Amphetamine-Related Disorders/epidemiology , Amphetamines/adverse effects , Central Nervous System Stimulants/adverse effects , Adult , Amphetamine-Related Disorders/prevention & control , Female , Humans , Male , Netherlands , Seizures/chemically induced , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...